Evidence map›Paper›PMID 37110467›Full record

ReviewMicroorganisms2023

The Exploitation of Microbial Antagonists against Postharvest Plant Pathogens.

Lamenew Fenta, Habtamu Mekonnen, Negash Kabtimer

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
21.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 53 citations in OpenAlex.

  1. Proteomic analysis of rose apple reveals defense proteins activated during Lasiodiplodia theobromae infection.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Identification and Aggressiveness ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lamenew FentaDepartment of Biology, Debre Markos University, Debre Markos P.O. Box 269, Ethiopia.
Habtamu MekonnenDepartment of Biology, Bahir Dar University, Bahir Dar P.O. Box 79, Ethiopia.
Negash KabtimerDepartment of Biology, Bahir Dar University, Bahir Dar P.O. Box 79, Ethiopia.ORCID 0000-0003-1122-9452
Bahir Dar University · ETDebre Markos University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Postharvest disease management is vital to increase the quality and productivity of crops. As part of crop disease protection, people used different agrochemicals and agricultural practices to manage postharvest diseases. However, the widespread use of agrochemicals in pest and disease control has detrimental effects on consumer health, the environment, and fruit quality. To date, different approaches are being used to manage postharvest diseases. The use of microorganisms to control postharvest disease is becoming an eco-friendly and environmentally sounds approach. There are many known and reported biocontrol agents, including bacteria, fungi, and actinomycetes. Nevertheless, despite the abundance of publications on biocontrol agents, the use of biocontrol in sustainable agriculture requires substantial research, effective adoption, and comprehension of the interactions between plants, pathogens, and the environment. To accomplish this, this review made an effort to locate and summarize earlier publications on the function of microbial biocontrol agents against postharvest crop diseases. Additionally, this review aims to investigate biocontrol mechanisms, their modes of operation, potential future applications for bioagents, as well as difficulties encountered during the commercialization process.

Indexed as

disease developmentmicrobial biocontrolpostharvest diseasespostharvest loss

Identifiers

PMID37110467
PMCPMC10143894
OpenAlexW4366091681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.